2025年欧洲肿瘤内科学会ESMO乳腺癌大会

◆ 会议时间：2025年5月14-16日
◆ 会议地点：德国 慕尼黑(Munich)

◆ 会议简介：

2025年欧洲肿瘤内科学会(ESMO)乳腺癌年会/大会将于2025年5月14-16日在德国慕尼黑举行。ESMO乳腺癌年会是在欧洲举行的一个多学科全球会议，由全球公认的一流专家参与，是所有对创新、转化肿瘤学和护理感兴趣的乳腺癌研究人员和临床医生的进行交流的平台，预计有超过800名专业人士出席会议。

欧洲肿瘤内科学会（ESMO）成立于1975年，是欧洲领先的肿瘤内科学专业组织，现在全球150多个国家和地区拥有超过23,000名会员，是肿瘤学教育和信息的参考学会，ESMO致力于支持其会员在快速发展的专业环境中得到宣发展与进步。作为一个非营利组织，ESMO一直以推动癌症护理和治疗为使命，致力于推进肿瘤医学专业的发展，以多学科的方法来促进癌症的治疗和护理。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

ESMO BREAST CANCER ANNUAL CONGRESS 2025

Date:
14 – 16 May 2025

Venue:
Munich, Germany

Organized by:
European Society for Medical Oncology (ESMO)

ESMO Breast Cancer 2025 will take place in Munich, Germany, from 14 to 16 May 2025, as well as online, through a dedicated virtual platform.

Join us at this focused event that will bring together international experts in the field to explore the latest innovations, discuss cutting-edge treatments and collaborate on strategies to improve patient outcomes.

We aim to provide fresh insights into the most recent advancements in breast cancer diagnosis, treatment and survivorship, by offering a comprehensive overview of the current landscape of breast cancer care.

Share experiences, exchange ideas and forge meaningful collaborations with renowned experts in the field.

摘要征文投稿：

Abstract submission deadlines

点此提交摘要>>>Submit Abstract>>>

• 提交指南>>>ESMO Breast Cancer 2025 Abstract Regulations

Outcome notifications

Outcome notifications of regular abstracts are expected to be made available to first authors and submitters by mid-March 2025.

Outcome notifications of accepted full LBAs are expected to be made available to first authors and submitters by end-April 2025. 

Information for presenters 

Detailed instructions for the preparation of slide presentations and/or posters will be made available by mid-March in the section “Information for Presenters”. 

Abstract submission categories

• Biomarkers and translational research and precision medicine
• Early breast cancer: Surgery and radiotherapy
• Early breast cancer: Systemic treatments
• Early detection, hereditary breast cancer and prevention
• Metastatic breast cancer
• Supportive care and survivorship
• Miscellaneous

Late-breaking abstracts

Late-breaking abstracts may be submitted for high quality, new research findings from prospective interventional clinical trials or observational series or novel technologies with major implications for clinical practice and/or understanding and targeting of disease processes.

The final late-breaking abstract deadline of 15 April 2025 is under no circumstances to be considered as an extension of the general submission deadline (11 February 2025).

Trial in Progress abstracts

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to ESMO Breast Cancer 2025.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis.

Presentation and publication of accepted abstracts

The Breast Cancer 2025 Scientific Committee will select abstracts for presentation during the Congress and determine the format of the presentations from the following possibilities:

• Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives. 
• Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
• Poster – Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.

All accepted abstracts, including Late-breaking, will be published online in the ESMO Breast Cancer 2025 Abstract Book, a supplement to the official ESMO journal, ESMO Open.

Publication schedule of accepted abstracts

Abstracts accepted for presentation during the ESMO Breast Cancer 2025 will be released online according to a schedule which will be available on the ESMO website in due course.

ESMO Merit Travel Grant

A restricted number of ESMO Merit Travel Grants to the ESMO Breast Cancer 2025 are available, upon application, to first author (= presenter) who submit abstracts considered to be deserving of recognition. Candidates must be ESMO Members under the age of 40. Selection will be made by the ESMO Breast Cancer 2025 Scientific Committee on a competitive basis from among the accepted abstracts.

ESMO BC 2025 注册费：

Registration includes:

• Participation in scientific and educational live sessions with the possibility to interact with the expert panel table
• Onsite networking opportunity with faculty and peers
• Entry to the Poster and e-Poster area
• Interaction with the industry partners in the trade exhibition
• Participation in the Industry Satellite Symposia
• Access to the Virtual Platform to view live-streamed sessions and to view the missed sessions on-demand
• Post-congress resources
• Coffee breaks

Registration fees and deadlines

Individual registration will remain open for the duration of the congress. The ESMO Congress Secretariat must receive one completed registration per participant and the corresponding payment in EUR by the given deadlines.

ESMO Membership must be active seven (7) days prior to the registration deadline for the reduced member registration fee to be applied. Please visit the membership page to check eligibility criteria, benefits, and to complete the membership application.

*Applicable to ESMO Members from developing countries only. At the time of application, developing countries are defined by ESMO according to the World Bank classification of low, lower-middle and upper-middle countries based on the Gross National Income (GNI) per capita. Download the PDF outlining which countries are eligible for the discounted registration fees.

**ESMO Members must be under 40 and in training to qualify for this fee.

Please send an email to registration@esmo.org to request one of the badge in the table above “Other registration fees”. 

Webcasts 

The official sessions and Industry Satellite Symposia will be available on-demand on the Congress Virtual Platform until 19 May at 16:00 CEST, for all registered participants. Once the Congress Virtual Platform is closed, the on-demand content will be transferred to OncologyPRO.

Sessions from the official congress programme 

Registered delegates (both ESMO Members and Non-members) and ESMO Members can access resources on OncologyPRO from 19 May 2025 for 2 years. 

Satellite Symposia 

Satellite Symposia webcasts will be available on OncologyPRO or ESMO website (only if permission has been granted by the Pharma Company) for ESMO members and registered delegates, from 19 May 2025 for 2 years.